GreylockSec
Posted - 6 days ago
$TPST @OA_Trades You're exactly right! And, I don't know if it's coincidence or intuition on your part but that number you picked of $9.77 happens to be the new strike price for the 60-day options that were just awarded to Brady and his whole team (thanks to Peter PRG for posting the table!)..!! Equally as interesting, Brady & N. Maestas-CFA, were both at Immune Design and began looking for investment dollars starting in mid-2018. As talks progressed, only 9 months later, Merck just decided instead to buy them out for $300 million! That stock was selling for around a $1.00 too, and shot up to $6 after the buyout offer. As I remember other notable biotechs (briefly and with great regret that I already had sold my Harpoon for peanuts ) both $HARP and Summit were shunned by the market just before their 2,000% explosions....
Winpicks
Posted - 1 week ago
$TPST $HARP The '60-day stock-options' for staff are also very sussy, in a good way. Brady may sell out after all
GreylockSec
Posted - 1 week ago
$TPST @Bofus @TAKERS1 @TropicalSmoothieCafe @Rocker999 @dload7 @OA_Trades I just wanted to add that It sucks to lose any kind of hard earned cash & I see some have unfortunately lost a lot, especially when we come onto the scene believing everything that the CEO's are telling us. I guess it's similar to relationships; we believe what you say, until you start lying to us, such as w/ the over-zealous dilution. I'm out for now, but I will definitely pounce down hard on Tempest once the volume ticks down & we fill (some) of the gap from the $0.26 to $0.863 range. The science speaks for itself & this certainly will help Roche sell more of its medicines, especially since the 0.65 hazard ratio for PH2 was amazing. -Short/Int. actually went down from 3.7M to 2.64M. -Additionally, Roche is still in for PH3, and both $HARP & Summit both went thru this hell before they exploded up 2,000%. -The '60-day stock-options' for staff are also very sussy, in a good way. Brady may sell out after all! GLTA!
GreylockSec
Posted - 2 weeks ago
$TPST @PRG2022 Brother, I get that, I really do, ....but it's not always "get the pre-funded Warrants & then cash them in for shares days later.." ...Much of the deals that are made with a private placement from VC's (who are really good at smelling desperation) will wait months and months before cashing in, and, as you say, diluting...What I believe Brady & Maestas (CFA) understand is that this company NEEDS CASH NOW to support funding for big costly trials w/ 700 patients. And I believe Brady is willing to have some dilution down the road (much like what happened with $HARP) in exchange for not giving away valuable Rights to sell the drug for VC-Cash....everyone on Wall-Street & I think Brady does too, understands that you can't get big dollars without giving away something. But Commercial Rights are the Holy Grail & that's what will give Tempest the ability to sell itself in late '2025 /'2026 for $45/share, or a billion dollar valuation! But again Peter, $$$ money is needed today!!
GreylockSec
Posted - 2 weeks ago
@PRG2022 Brother, I get that, I really do, ....but it's not always "get the pre-funded Warrants & then cash them in for shares days later.." ...Much of the deals that are made with a private placement from VC's (who are really good at smelling desperation) will wait months and months before cashing in, and, as you say, diluting...What I believe Brady & Maestas (CFA) understand is that this company NEEDS CASH NOW to support funding for big costly trials w/ 700 patients. And I believe Brady is willing to have some dilution down the road (much like what happened with $HARP) in exchange for not giving away valuable Rights to sell the drug for VC-Cash....everyone on Wall-Street & I think Brady does too, understands that you can't get big dollars without giving away something. But Commercial Rights are the Holy Grail & that's what will give Tempest the ability to sell itself in late '2025 /'2026 for $45/share, or a billion dollar valuation! But again Peter, $$$ money is needed today!! $TPST
John_D_Stockefeller
Posted - 2 weeks ago
@MS_Tammy Well, ZyVersa’s “sister company”, AMAM, went through some ups and downs, and I had little trust or faith in management, but I stuck with it for a long while. It paid off when they got bought out. Same with $HARP. Stuck with it, through a r/s that I tripled down on afterwards. It got bought out and I made good bank. I’m in for the whole haul.
StonkZombie
Posted - 10/29/24
@look2theblue Richard Hunt, on the BoD, is the guy to pay attention to. Look at this track record of being on the boards of companies that were acquired by heavy hitters. Mr. Hunt was previously on the boards of Harpoon Therapeutics Inc. (Nasdaq: $HARP, acquired by Merck & Co.), Neuronetics, Inc. (Nasdaq: $STIM), Durata Therapeutics (Nasdaq: $DRTX, acquired by Actavis), Relypsa (Nasdaq: $RLYP), Cerexa (acquired by Forest Laboratories), Stromedix, Inc. (acquired by Biogen Idec), Aspreva Pharmaceuticals (Nasdaq: $ASPV, acquired by Galenica, Inc.), Phase Forward (Nasdaq: $PFWD, acquired by Oracle), and Pathology Partners (acquired by Caris Group).
John_D_Stockefeller
Posted - 4 months ago
@John___wick44 So sorry for your many losses. My story, with $HARP and $AMAM both getting bought out at a nice premium on the same day, is different.
Azzoz
Posted - 4 months ago
$CNTX $HARP
georgeqi
Posted - 4 months ago
$CNTX $HARP acquired by Merk with just one pipeline for 650M similar like recent acquired CT95, so $CNTX could worth 4×-6× if it is acquired by other big companies, $8-$12 is reasonable price in 2025 once 2 phase 1 results are out..
John_D_Stockefeller
Posted - 4 months ago
@telomerase @Chemaster btw, i was in both $HARP and $AMAM from a couple of bucks, to buyouts well into in the $20s. Have a couple right now that are set up for similar outcomes, imo.
John_D_Stockefeller
Posted - 5 months ago
@Trubach Definitely not comparing the stock or company. Just pointing out that contrary to message board belief systems, a reverse split does not always spell doom. Many companies do quite well after a r/s, depending on all other variables. I had been holding and adding $HARP for almost a year, when they announced a r/s forthcoming last fall. I believed in them enough to more than triple down when the price plunged. In January they were bought out for a nice premium. Cha-Ching.
John_D_Stockefeller
Posted - 5 months ago
@jcooptechit Welp, not always true. I bought, added to, and held both $AMAM and $HARP through a period of about 15 months. Both endured severe ups and downs, and HA RP had a reverse split along the way. i got in early, and they both got bought out in January. Made a tidy sum on both. Many small would do fine, continue to grow and prosper…..if day traders and flippers jumped off a cliff.
John_D_Stockefeller
Posted - 6 months ago
@John___wick44 Bought $HARP, added, held. Held through 1:10 reverse split, tripled down. Woke up and logged on after the year-long + endeavor to see it got BO at many multiples of my entries. Drugs in pipeline, $16 PT, other reasons to hold. Plus, up close to 50% currently.
John_D_Stockefeller
Posted - 6 months ago
@Billy_Striebeck BTW, I was in deep with $HARP well over a year ago, held and added, right through a 1:10 reverses split. Afterwards, I tripled down, and held. the share price recovered, rose again steadily, and I believe it was in January, I woke up to news of it being bought out. Was about a 600% gain from the lows I had bought at, both prior to, and after the reverse split. Not all reverse splits are created equally. Holding 100 shares. I’ll be okay. Have a great day!
GSMITH10107
Posted - 6 months ago
$BCAB I also wanted to add to this - CEO Jay Short is no joke - go look at his background and history. he also put his money where his mouth is - he owns 3.5 million shares of BCAB .. $CTMX is trading at approx 300 million market cap in the same sector.. why is BCAB trading only at 150 million market cap? two assets are in phase 2, while CTMX is only in phase 1.. then they would argue CTMX partnership with amgen / data right around the corner well guess what - $BCAB has multiple data readouts the next 60 days and CEO has essentially guaranteed a Big Pharma partnership in December.. so why half the valuation of $CTMX ????????? makes no sense to me I think it would be ludicrous to sell my shares here.. just my honest opinion what if it does make a $harp $janx type move.. worth a gamble FOR ME
BiotechValues
Posted - 7 months ago
$SRZN @raticals brought up a good point on $HARP. Despite doing a large PIPE Oct 23, 2023, they were bought out ~3 months later by Merck on Jan 8, 2024. From a tiny $15M market cap before the PIPE, to $680M buyout in a few months. Did HARP know Merck was interested, but not ready? Or was it a surprise after the PIPE? https://www.streetinsider.com/Corporate+News/Harpoon+Therapeutics+Inc.+%28HARP%29+Announces+Up+to+%24150+Million+Private+Placement/22298383.html
Bull_Bros
Posted - 7 months ago
Reminiscing $HARP- had a nice gain here, but boy did we get screwed by that PIPE financing -for longs who held before RS. Rigged game 🤔
Yourmatefromdownunder
Posted - 8 months ago
$HARP Woohoo$$$ Cash pouring in! Also got lots more in $3’s and $4’s Holding but have stops in…… just in case!
svong1175
Posted - 8 months ago
$CLRB Possibly heading the same way here as $HARP? Sept 1st 2023 trading closed $10.70 1:10 RSS announced Dipped to $3.30 by mid October 2023 Back up to high $10s by early January 2024 Acquired by Merck for $23 on January 8th 2024 Maybe, maybe not 🤷
Solfer
Posted - 8 months ago
$MCRB Possibly heading the same way here as $HARP?
Sept 1st 2023 trading closed $10.70
1:10 RSS announced Dipped to $3.30 by mid October 2023
Back up to high $10s by early January 2024
Acquired by Merck for $23 on January 8th 2024
Maybe, maybe not 🤷
Rehypothecation
Posted - 8 months ago
$HARP Merck $MRK buys 21,397,205 shares of Harpoon Therapeutics $HARP for $492,135,712 on 3-11-2024
insiderbuyingselling
Posted - 8 months ago
$HARP new insider buying: 21397205 shares. http://insiderbuyingselling.com/?t=HARP
rob8311
Posted - 8 months ago
$HARP So when does the money hit?
momeymaker1
Posted - 8 months ago
$HARP unbelievable
Stock_Titan
Posted - 8 months ago
$MRK $HARP Merck Completes Acquisition of Harpoon Therapeutics, Inc.
https://www.stocktitan.net/news/MRK/merck-completes-acquisition-of-harpoon-therapeutics-dkhx2hesk5ag.html
tradethehalt
Posted - 8 months ago
$HARP trade halt (T12) was alerted to our Members at 7:50pm EST. Halt price: $23.00 Vol: 6.62M.
Mergerbrief
Posted - 8 months ago
$HARP $MRK - Shareholder Vote $HARP mergerbrief.com
svong1175
Posted - 8 months ago
@kylebraun21 What if the share holders voted and ask for more $ and the deal fell through . What happen to $HARP will it maintain the price of $23 or drop back to down ?
